Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experience

Documenti analoghi

• Somatic co‐alteration signatures are prognostic in high‐grade TP53‐mutated myeloid neoplasms
  di: Emily O. Symes, et al.
  Pubblicazione: (2024)
• Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis
  di: Huimin Jin, et al.
  Pubblicazione: (2025)
• Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms
  di: Iván Martín Castillo, et al.
  Pubblicazione: (2024)
• Unveiling myeloid transformation: T‐LGLL with eosinophilia masking myeloid‐associated STAT5B mutation culminating in AML
  di: Qianze Dong, et al.
  Pubblicazione: (2024)
• Decoding the molecular drivers of TP53 ‐mutant acute myeloid leukaemia: Clinical implications and prognostic insights
  di: Lin‐Ya Wang, et al.
  Pubblicazione: (2025)